ARCHIVES

NS Sponsors Workshop On Prevention For Three Minority Groups

This article is from The Cancer Letter archive.

Vol. 14 No. 27 | July 1, 1988

Download PDF Visit The Full Archive

Related Articles

Phase II Study Finds Dasatinib May Overcome ALL Resistance

May 25, 2007

Legacy CEO Cheryl Healton says foundation could serve as funder for research on “potentially reduced-exposure products.”

October 29, 2004

OAM Advisor’s Faxes Promote Alternatives, Cassileth Writes To NIH

September 3, 1993

Kushner Forms BreastPac

June 17, 1988

Survey Finds 70 Percent of Oncologists Prescribe Avastin Off-Label For Ovarian Cancer

August 30, 2013

Referral Pattern Change Needed For Quality Care, AACR/ASCO Told

May 16, 1975